Index -
P/E -
EPS (ttm) -0.50
Insider Own 45.57%
Shs Outstand 51.03M
Perf Week -4.12%
Market Cap 89.62M
Forward P/E -
EPS next Y -0.56
Insider Trans 1.03%
Shs Float 29.93M
Perf Month -11.89%
Income -25.65M
PEG -
EPS next Q -0.12
Inst Own 6.30%
Short Float 1.97%
Perf Quarter 58.25%
Sales 0.00M
P/S -
EPS this Y 0.00%
Inst Trans 329.88%
Short Ratio 0.19
Perf Half Y 50.93%
Book/sh 0.41
P/B 4.01
EPS next Y -12.00%
ROA -52.93%
Short Interest 0.59M
Perf Year 50.93%
Cash/sh 0.38
P/C 4.34
EPS next 5Y -
ROE -78.85%
52W Range 0.84 - 7.80
Perf YTD 59.80%
Dividend Est. -
P/FCF -
EPS past 5Y 47.53%
ROI -64.01%
52W High -79.10%
Beta 3.26
Dividend TTM -
Quick Ratio 4.03
Sales past 5Y -30.20%
Gross Margin -
52W Low 94.05%
ATR (14) 0.15
Dividend Ex-Date -
Current Ratio 4.03
EPS Y/Y TTM 0.81%
Oper. Margin 0.00%
RSI (14) 39.45
Volatility 6.61% 6.52%
Employees 44
Debt/Eq 1.00
Sales Y/Y TTM -
Profit Margin -
Recom 1.00
Target Price 8.00
Option/Short Yes / Yes
LT Debt/Eq 0.93
EPS Q/Q 17.76%
Payout -
Rel Volume 0.04
Prev Close 1.70
Sales Surprise -
EPS Surprise 14.29%
Sales Q/Q -
Earnings Mar 26 BMO
Avg Volume 3.11M
Price 1.63
SMA20 -14.96%
SMA50 -14.47%
SMA200 30.06%
Trades
Volume 110,663
Change -3.83%
Mar-26-24 09:02PM
01:52PM
08:38AM
(Associated Press Finance)
08:30AM
Mar-06-24 08:00AM
07:49AM
Loading…
Mar-01-24 07:49AM
Feb-28-24 01:59PM
08:30AM
Nov-14-23 06:10AM
(Associated Press Finance) -6.27%
06:00AM
Oct-16-23 06:00AM
Sep-13-23 09:25PM
Sep-07-23 06:00AM
Sep-05-23 06:00AM
Aug-14-23 05:56PM
(Associated Press Finance)
05:45PM
Loading…
05:45PM
Jul-11-23 06:00AM
Jun-14-23 06:00AM
Jun-13-23 06:05AM
(Simply Wall St.) +16.30%
May-15-23 06:21AM
06:15AM
May-03-23 06:57AM
06:26AM
Apr-04-23 06:00AM
Mar-31-23 02:50PM
Mar-21-23 06:00AM
Dec-01-22 09:42AM
Nov-14-22 04:46PM
Oct-17-22 06:00AM
Vivani Medical, Inc. is a preclinical stage biopharmaceutical company, which engages in the business of developing miniaturized, subdermal implants utilizing proprietary NanoPortal technology to enable long-term, near constant-rate delivery of a broad range of medicines to treat chronic diseases. It operates under the Biopharm Division and Neuromodulation Division segments. The company was founded by Adam Mendelsohn on May 22, 2003 and is headquartered in Alameda, CA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Williams Gregg Director Feb 15 '24 Buy 1.01 1,078 1,089 727,608 Feb 20 06:32 PM Williams Gregg Director Feb 09 '24 Buy 1.01 1,071 1,082 726,530 Feb 09 08:02 PM Williams Gregg Director Feb 08 '24 Buy 1.01 1,119 1,130 725,459 Feb 09 08:02 PM Williams Gregg Director Feb 06 '24 Buy 1.01 56 57 724,340 Feb 06 06:35 PM Williams Gregg Director Feb 05 '24 Buy 1.01 1,939 1,958 724,284 Feb 06 06:35 PM Williams Gregg Director Jan 31 '24 Buy 1.01 100 101 722,345 Feb 02 08:04 PM Williams Gregg Director Jan 23 '24 Buy 1.01 834 842 722,245 Jan 25 06:31 PM Williams Gregg Director Jan 22 '24 Buy 1.01 7,620 7,696 721,411 Jan 22 06:54 PM Williams Gregg Director Jan 19 '24 Buy 1.01 77 78 713,791 Jan 19 07:27 PM Williams Gregg Director Jan 18 '24 Buy 1.01 999 1,009 713,714 Jan 19 07:27 PM Williams Gregg Director Jan 16 '24 Buy 1.01 13,067 13,198 712,715 Jan 16 07:24 PM Williams Gregg Director Jan 08 '24 Buy 1.08 6,731 7,269 699,648 Jan 09 08:10 PM Williams Gregg Director Jan 05 '24 Buy 1.08 2,000 2,160 692,917 Jan 05 06:57 PM Williams Gregg Director Jan 04 '24 Buy 1.07 4,200 4,494 690,917 Jan 05 06:57 PM Williams Gregg Director Jan 03 '24 Buy 1.01 3,563 3,599 686,717 Jan 03 08:40 PM Williams Gregg Director Jan 02 '24 Buy 1.01 3,548 3,583 683,154 Jan 03 08:40 PM Williams Gregg Director Dec 22 '23 Buy 1.00 100 100 679,606 Dec 27 06:15 PM Williams Gregg Director Dec 21 '23 Buy 0.88 149,940 131,947 679,506 Dec 21 08:08 PM Williams Gregg Director Dec 20 '23 Buy 0.88 3,734 3,286 529,566 Dec 21 08:08 PM Williams Gregg Director Dec 19 '23 Buy 0.86 198 170 525,832 Dec 21 08:08 PM Williams Gregg Director Dec 18 '23 Buy 0.90 2,000 1,800 525,634 Dec 18 08:29 PM Makes Brigid CFO Dec 18 '23 Buy 0.87 1,000 870 15,000 Dec 18 08:27 PM Makes Brigid CFO Dec 15 '23 Buy 0.89 4,000 3,560 14,000 Dec 18 08:27 PM Williams Gregg Director Dec 15 '23 Buy 0.89 2,000 1,780 523,634 Dec 18 08:29 PM Williams Gregg Director Dec 14 '23 Buy 0.88 301 265 521,634 Dec 18 08:29 PM Williams Gregg Director Dec 13 '23 Buy 0.87 858 746 521,333 Dec 13 07:46 PM Williams Gregg Director Dec 11 '23 Buy 0.89 28,948 25,764 520,475 Dec 13 07:46 PM Williams Gregg Director Dec 06 '23 Buy 0.96 993 953 491,527 Dec 08 07:15 PM Williams Gregg Director Nov 24 '23 Buy 0.95 2,694 2,559 490,534 Nov 27 06:23 PM Dwyer Donald Chief Business Officer Nov 22 '23 Buy 0.96 1,000 960 36,500 Nov 22 05:04 PM Williams Gregg Director Nov 22 '23 Buy 0.95 769 731 487,840 Nov 27 06:23 PM Dwyer Donald Chief Business Officer Nov 21 '23 Buy 0.96 2,000 1,920 35,500 Nov 22 05:04 PM Dwyer Donald Chief Business Officer Nov 20 '23 Buy 0.96 2,500 2,400 33,500 Nov 22 05:04 PM Williams Gregg Director Nov 17 '23 Buy 0.95 1,251 1,188 487,071 Nov 20 08:36 PM Williams Gregg Director Nov 16 '23 Buy 0.95 2,015 1,914 485,820 Nov 20 08:36 PM Williams Gregg Director Oct 24 '23 Buy 1.00 1,222 1,222 483,805 Oct 24 06:44 PM Williams Gregg Director Oct 23 '23 Buy 1.00 100,565 100,565 482,583 Oct 24 06:44 PM Williams Gregg Director Oct 20 '23 Buy 1.00 1,581 1,581 382,018 Oct 24 06:44 PM Williams Gregg Director Oct 16 '23 Buy 1.00 1,600 1,600 380,437 Oct 16 06:12 PM Williams Gregg Director Oct 13 '23 Buy 1.01 9,414 9,508 378,837 Oct 16 06:12 PM Williams Gregg Director Oct 12 '23 Buy 1.00 1,405 1,405 369,423 Oct 16 06:12 PM Williams Gregg Director Oct 09 '23 Buy 1.00 664 664 368,018 Oct 11 09:08 PM Williams Gregg Director Oct 06 '23 Buy 1.02 87,887 89,645 367,354 Oct 10 08:40 PM Williams Gregg Director Oct 05 '23 Buy 1.00 1,424 1,424 279,467 Oct 05 08:38 PM Williams Gregg Director Oct 04 '23 Buy 1.00 5,452 5,452 278,043 Oct 05 08:38 PM Williams Gregg Director Oct 03 '23 Buy 1.00 3,048 3,048 272,591 Oct 05 08:38 PM Williams Gregg Director Oct 02 '23 Buy 1.00 16,207 16,207 269,543 Oct 02 07:14 PM Williams Gregg Director Sep 28 '23 Buy 1.03 20,003 20,603 253,336 Oct 02 07:14 PM Williams Gregg Director Sep 27 '23 Buy 1.00 1,026 1,026 233,333 Sep 27 07:51 PM Dwyer Donald Chief Business Officer Sep 27 '23 Buy 1.01 1,000 1,010 31,000 Sep 27 07:53 PM Williams Gregg Director Sep 26 '23 Buy 0.94 1,567 1,473 232,307 Sep 27 07:51 PM Williams Gregg Director Sep 25 '23 Buy 0.95 24,088 22,884 230,740 Sep 27 07:51 PM Williams Gregg Director Sep 21 '23 Buy 0.93 398 370 206,652 Sep 22 08:34 PM Williams Gregg Director Sep 20 '23 Buy 0.92 21,028 19,346 206,254 Sep 22 08:34 PM Williams Gregg Director Sep 18 '23 Buy 0.96 66,743 64,073 185,226 Sep 18 07:46 PM Williams Gregg Director Sep 14 '23 Buy 0.95 35,036 33,284 118,483 Sep 18 07:46 PM Williams Gregg Director Sep 12 '23 Buy 0.96 5,145 4,939 83,447 Sep 12 09:12 PM Williams Gregg Director Sep 11 '23 Buy 0.95 1,854 1,761 78,302 Sep 12 09:12 PM Williams Gregg Director Sep 08 '23 Buy 0.94 6,998 6,578 76,448 Sep 12 09:12 PM Williams Gregg Director Sep 07 '23 Buy 0.94 33,700 31,678 69,450 Sep 07 06:17 PM Williams Gregg Director Sep 06 '23 Buy 0.94 14,570 13,696 35,750 Sep 07 06:17 PM Williams Gregg Director Sep 05 '23 Buy 0.93 4,997 4,647 21,180 Sep 07 06:17 PM Williams Gregg Director Sep 01 '23 Buy 0.94 10,888 10,235 16,183 Sep 01 09:24 PM Makes Brigid CFO Sep 01 '23 Buy 0.94 4,000 3,780 10,000 Sep 05 07:04 PM Dwyer Donald Chief Business Officer Aug 31 '23 Buy 0.94 7,500 7,050 30,000 Sep 05 07:06 PM Williams Gregg Director Aug 31 '23 Buy 0.92 5,295 4,871 5,295 Sep 01 09:24 PM Makes Brigid CFO Aug 31 '23 Buy 0.90 2,000 1,800 6,000 Sep 05 07:04 PM Dwyer Donald Chief Business Officer Aug 17 '23 Buy 1.08 7,500 8,100 22,500 Aug 18 02:43 PM Makes Brigid CFO Jun 28 '23 Buy 1.21 3,000 3,630 4,000 Jun 29 12:43 PM Makes Brigid CFO Jun 27 '23 Buy 1.24 1,000 1,240 1,000 Jun 29 12:43 PM Dwyer Donald Chief Business Officer Jun 22 '23 Buy 1.24 5,000 6,200 15,000 Jun 26 11:03 AM Mendelsohn Aaron Director Jun 09 '23 Buy 1.30 10,000 12,980 188,170 Jun 12 09:32 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite